Watchful Waiting after Radiochemotherapy in Rectal Cancer : When Is It Feasible?
A "watch and wait" strategy in rectal cancer is increasingly considered in patients who achieve an excellent response to radiotherapy. While a growing number of studies have shown the feasibility of this strategy in selected patients, the optimal therapeutic regimen to maximize response rates still needs to be established. Furthermore, accurate response prediction and the management of minor residual findings after radiotherapy remain a matter of debate. Finally, concerns regarding the long-term oncological safety of the "watch and wait" approach have been expressed. Therefore, the present review aims to address the open questions in the context of a "watch and wait" strategy and focuses on the diagnosis of a clinical complete response and the ideal management thereafter.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Visceral medicine - 35(2019), 2 vom: 03. Apr., Seite 119-123 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gani, Cihan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cancer |
|---|
| Anmerkungen: |
Date Revised 30.09.2020 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1159/000499167 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM298091348 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM298091348 | ||
| 003 | DE-627 | ||
| 005 | 20231225093417.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000499167 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0993.xml |
| 035 | |a (DE-627)NLM298091348 | ||
| 035 | |a (NLM)31192245 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gani, Cihan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Watchful Waiting after Radiochemotherapy in Rectal Cancer |b When Is It Feasible? |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 30.09.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a A "watch and wait" strategy in rectal cancer is increasingly considered in patients who achieve an excellent response to radiotherapy. While a growing number of studies have shown the feasibility of this strategy in selected patients, the optimal therapeutic regimen to maximize response rates still needs to be established. Furthermore, accurate response prediction and the management of minor residual findings after radiotherapy remain a matter of debate. Finally, concerns regarding the long-term oncological safety of the "watch and wait" approach have been expressed. Therefore, the present review aims to address the open questions in the context of a "watch and wait" strategy and focuses on the diagnosis of a clinical complete response and the ideal management thereafter | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Complete response | |
| 650 | 4 | |a Organ preservation | |
| 650 | 4 | |a Radiotherapy | |
| 650 | 4 | |a Rectal cancer | |
| 700 | 1 | |a Kirschniak, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Zips, Daniel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Visceral medicine |d 2016 |g 35(2019), 2 vom: 03. Apr., Seite 119-123 |w (DE-627)NLM262401630 |x 2297-4725 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2019 |g number:2 |g day:03 |g month:04 |g pages:119-123 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1159/000499167 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2019 |e 2 |b 03 |c 04 |h 119-123 | ||